Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Nov 17, 2015
0
996
An important class of drug used to treat cancer patients could be used to treat brain aneurysms, according to new research published this week.
May 17, 2019
0
154
Nearly 100 percent of cancer patients with solid tumors have antibodies effective against the delta variant after a third dose of COVID-19 vaccine, according to new results published as a correspondence in Cancer Cell this ...
Dec 23, 2021
0
59
An immunotherapy harnessing the immune system's "natural killer" cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of ...
Dec 14, 2021
0
36
Increasingly dense cell clusters in growing tumors convert blood vessels into fiber-filled channels. This makes immune cells less effective, as findings by researchers from ETH Zurich and the University of Strasbourg suggest. ...
Mar 17, 2023
0
65
Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them. However, in people with compromised immunity, such as transplant and cancer patients, as well as hospitalized ...
Sep 12, 2022
0
148
Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Pa-tients for whom therapy does not work can ...
Jan 8, 2018
1
272
Johns Hopkins Kimmel Cancer Center investigators report they have designed a blood test that accurately detects the presence of advanced breast cancer and also holds promise for precisely monitoring response to cancer treatment.
Apr 15, 2014
0
0
New research by Sussex scientists could be the first step towards developing a blood test to diagnose the most aggressive type of brain tumour, known as glioblastoma.
Aug 19, 2019
0
272
Neural stem cells (NSCs) engineered by Northwestern Medicine investigators used in combination with the HER2 inhibitor drug tucatinib improved survival in mice with HER2-positive breast cancer brain metastases, according ...
Feb 2, 2022
0
97
